Stämm’s Post

𝟗𝟎% 𝐨𝐟 𝐥𝐞𝐚𝐝𝐞𝐫𝐬 𝐚𝐫𝐞 𝐨𝐩𝐭𝐢𝐦𝐢𝐬𝐭𝐢𝐜 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬. But what’s standing in the way of commercialization? While “payer and reimbursement challenges” remains the top force affecting the commercialization of advanced therapies in the next 12–18 months, this year it tied for the top position with “𝐢𝐦𝐩𝐫𝐨𝐯𝐞𝐝 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲,” underscoring a push toward consistency and lower cost of goods sold (COGS)… Thanks Daniella Kranjac! #deloitte #manufacturing #costofgoods #celltherapy #advancedtherapies #regenerativemedicine #optimism #commercialbarriers #costofgoods #manufacturingtechnology #improvedtechonology #biotech #biotechnology #lifesciences #lifescience #strategicinnovation #scalability #automation #operationalefficiencies https://lnkd.in/gHkPBD7w

Very excited to announce that in the upcoming ECI Single Use Technologies VII: Revolutionizing Manufacturing for Tomorrow’s Medicines conference, I will be chairing a session with Emelia DeForce and Jack Jeffries. We will be chairing a session on Sustainable Solutions in Single-Use Design and Manufacturing. This session signifies and acknowledges the collective efforts for an industry-wide approach to design and use single-use technology in a sustainable manner. The operational and economic benefits of single-use technologies in the manufacture of biopharmaceuticals and advanced therapies are known. However, these need to be balanced with the environmental impact of applying SUT. This session aims to highlight the wider industry efforts on the integration of environmental sustainability and the collective efforts in advancing opportunities for a circular bioeconomy. The focus is on exemplar case studies on sustainable single-use design and manufacture that covers the whole product life cycle involving raw materials and whole-system product outlook from design, manufacture, use and end-of-life of single-use technologies. Some of the questions we aim to tackle include but are not limited to: ●    Which products and operations have high environmental impact? ●    What does life-cycle-analysis (LCA) say about potential areas for improvement to reduce the environmental impact of SUT application and manufacture? ●    What tools, metrics and practices can we use to design and manufacture sustainable SUT? ●    What are the current challenges to apply LCA and other tools to gain insights on sustainability metrics? We want to hear about your work on making single use technologies more sustainable! We are inviting abstract submissions for the ECI Single Use Technologies VII: Revolutionizing Manufacturing for Tomorrow’s Medicines. Oral abstracts deadline: September 20th 2024 Poster abstracts deadline: December 17th 2024 Let us hear more about the advances in single-use technology that you are involved in. You can find out more about the conference here: https://lnkd.in/edHswRCU Don’t forget to sign up for the mailing list to receive the most up to date information.

🚀 What’s holding back anaerobic fermentation? The simple answer: no oxygen. This lack has long limited the complexity of products that can be made, especially in biotech and pharma. Izote Biosciences offers a groundbreaking solution. By introducing molecules that act like oxygen substitutes, they’re expanding the range of what can be produced in fermentation processes. This isn’t just a tweak—it’s a game-changer that could revolutionize fermentation tech, opening up new possibilities for efficiency and product diversity across industries. 🔬 #Biotech #Innovation #DeepTech #FutureOfBiotech #BeePartners

💡Latest Research: Global market for Microspheres circa $12 billion by 2029 💊 What are the latest trends Microsphere Technology? Microspheres, made from biodegradable proteins or polymers, sustain drug release, making them ideal for targeted therapies, especially in oncology. Beyond drug delivery, microspheres open new possibilities across industries—from next-gen coatings to thermal insulation. With tailored sizes, shapes, and materials, they drive advancements in pharmaceuticals, advanced materials, and more. The future of microspheres is filled with exciting opportunities, driven by expanding research into new, impactful applications. PSL's MSR™ MicroSphere Refiner automates aseptic microsphere production, enhancing reproducibility, recovery, and scalability for drug development with integrated filtration, drying, and PAT monitoring. Find out more about the future directions of Microsphere Technology. https://bit.ly/4fZ2KYK #Microspheres #PharmaceuticalManufacturing #PharmaProcessing #DrugDelivery #MicrosphereProcessing

Seeing a convergence of lifesaving technologies to address food insecurity, and sustainable global health accross our companies at bioMérieux, INSTITUT MÉRIEUX, Mérieux Développement SAS, Mérieux Université and Transgene

🍀 Exciting news for biotech! 🍀 The Commission has announced a comprehensive initiative aimed at addressing the challenges facing biotechnology and biomanufacturing. From enhancing research and facilitating the transfer of technology to the market to simplifying regulatory complexities and improving access to finance, these actions are designed to foster growth, innovation, and sustainability. ⏩ https://lnkd.in/eeFpbNNc  We look forward to leveraging these new initiatives to accelerate our projects. Stay tuned for updates on how we're advancing our contributions to biotech. #FibriTech #EUeic #eicAccelerator #Biotechnology #Biomanufacturing #Innovation #Sustainability

Check out the power of bringing People, Processes and Technology together. Register today to fast track your #digitalization journey. CSL Siemens Mescada

Why digital marketing for biotech products? 🤔 It's simple: to get seen, beat the competition, and bring groundbreaking solutions to those who need them most. Learn how strategic marketing fuels biotech breakthroughs and beyond. Read our blog 👉 https://hubs.li/Q02xhGgj0 #MetricBiotech, #digitalmarketing, #marketingstrategy, #Biotech, #healthtech, #LifeSciences

Join Guidehouse's Life Sciences Commercial Transformation leaders at the Fierce Biotech Summit in Boston on September 30. Connect with industry leaders and executives to learn about advancements, innovations, and the future of biotech. #productlaunch #biotech #innovation

Biotechnology manufacturing is a complex and highly regulated field that demands precision, consistency, and efficiency. To meet these requirements, biotech companies are increasingly turning to advanced automation and control systems. These technologies streamline processes, enhance productivity, and ensure compliance with stringent regulatory standards. Here, we explore some of the most popular automation and control systems used in biotech manufacturing. Read the blog here: https://lnkd.in/epzYSKAP